Sizing clinical trials when comparing bivariate time-to-event outcomes.
Ontology highlight
ABSTRACT: Clinical trials with multiple primary time-to-event outcomes are common. Use of multiple endpoints creates challenges in the evaluation of power and the calculation of sample size during trial design particularly for time-to-event outcomes. We present methods for calculating the power and sample size for randomized superiority clinical trials with two correlated time-to-event outcomes. We do this for independent and dependent censoring for three censoring scenarios: (i) the two events are non-fatal; (ii) one event is fatal (semi-competing risk); and (iii) both are fatal (competing risk). We derive the bivariate log-rank test in all three censoring scenarios and investigate the behavior of power and the required sample sizes. Separate evaluations are conducted for two inferential goals, eva
SUBMITTER: Sugimoto T
PROVIDER: S-EPMC5533151 | biostudies-literature | 2017 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA